FT 13258 Confirms Compliance with SEC Registration Rules
FT 13258 certifies compliance with SEC regulations in recent filing, reflecting stability in the investment trust industry.
Kyriakopoulos Panagiotis Divests 44 Shares of Euroholdings Ltd.
Kyriakopoulos Panagiotis reported a divestment of 44 shares in Euroholdings Ltd., reflecting changes in ownership dynamics in the transportation industry.
Touchstone Strategic Trust Files Summary Prospectus for Value Fund
Touchstone Strategic Trust has filed a summary prospectus for its Touchstone Value Fund, outlining fees and expenses for investors.
Touchstone Strategic Trust Files Summary Prospectus for Fund
Touchstone Strategic Trust has filed a summary prospectus for its Touchstone Large Cap Fund, detailing investment goals and fees.
Kyriakopoulos Panagiotis Sells 1,400 Shares of Euroseas Ltd.
Kyriakopoulos Panagiotis has sold 1,400 shares of Euroseas Ltd., indicating a change in ownership that could impact the maritime transportation sector.
Federated Hermes World Investment Series Reports NPORT-P Filing
Federated Hermes World Investment Series, Inc. files NPORT-P, detailing significant assets and performance metrics, reflecting ongoing industry trends.
Federated Hermes reports financial metrics in latest filing
Federated Hermes Fixed Income Securities, Inc. shares its financial metrics, showcasing total assets of $592.9 million and net assets of $569.5 million.
Federated Hermes Equity Funds reports latest financial data
Federated Hermes Equity Funds reveals financial data, showcasing significant assets and performance metrics that may impact investor confidence and industry dynamics.
Federated Hermes Total Return Government Bond Fund Reports Assets
Federated Hermes Total Return Government Bond Fund reports total assets of $184.64 million in its latest filing, reflecting its financial health in the investment sector.
Federated Hermes Total Return Series reports latest fund update
Federated Hermes Total Return Series, Inc. shares its latest fund performance metrics in a recent SEC filing, showcasing significant assets and investment strategies.
Kyriakopoulos Panagiotis Sells 2,067 Shares of EuroDry Ltd.
Kyriakopoulos Panagiotis sells 2,067 shares of EuroDry Ltd., reducing his holdings to 8,400 shares, signaling potential shifts in ownership strategy.
Federated Hermes Institutional Trust Reports Latest Portfolio Details
Federated Hermes Institutional Trust updates its portfolio with a net asset value of $615.2 million, reflecting its investment management strategy.
Federated Hermes World Investment Series reports portfolio update
Federated Hermes World Investment Series, Inc. updates its portfolio holdings, revealing a total net asset value of approximately $1.48 billion in its latest filing.
Federated Hermes Premier Municipal Income Fund Reports Assets
Federated Hermes Premier Municipal Income Fund reveals total assets of $153.1 million in its latest filing, highlighting its position in the municipal investment space.
Federated Hermes Managed Pool Series Reports Latest Financials
Federated Hermes Managed Pool Series shares its latest financials, revealing a net asset value of $157.2 million, highlighting its position in the investment industry.
Federated Hermes Adviser Series reports financial results
Federated Hermes Adviser Series releases financial results showing $192.6 million in total assets, impacting the investment management landscape.
Federated Hermes ETF Trust Reports Financial Update
Federated Hermes ETF Trust files NPORT-P, revealing total assets of $55.8 million and net assets of $55.1 million as of August 31, 2026.
Bertley acquires shares under Park National's incentive plan
Frederic M. Bertley acquires 301 shares of Park National Corp as part of the 2026 Long-Term Incentive Plan for Non-Employee Directors.
Judd acquires 301 shares in Park National Corp under incentive plan
Jason N. Judd acquires 301 shares in Park National Corp as part of the 2026 Long-Term Incentive Plan for Non-Employee Directors, reflecting alignment with shareholder interests.
Oncolytics Biotech Reveals Strong Data from GOBLET Study
Oncolytics Biotech shares promising data from its GOBLET study, highlighting pelareorep's potential in anal cancer treatment and beyond.